ERICA KILNOSKI: Open Payments
NPI 1245348127 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 64 payments from 17 companies in 2025. Trend: 2023 $762 · 2024 $718 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $152 |
| ABBVIE INC. | 12 | $151 |
| Novo Nordisk Inc | 8 | $136 |
| AstraZeneca Pharmaceuticals LP | 6 | $112 |
| Lilly USA, LLC | 4 | $73 |
| Abbott Laboratories | 3 | $68 |
| Lundbeck LLC | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 3 | $49 |
| PFIZER INC. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
Products named: EVENITY, MOUNJARO, UBRELVY, FREESTYLE LIBRE 3, REXULTI, QULIPTA, Rybelsus, Wegovy.
Industry payments across IA — which companies pay providers there.
